Asymmetric benzimidazoles and related compounds as potassium channel modulators

Details for Australian Patent Application No. 2004253447 (hide)

Owner Icagen, Inc.

Inventors Wang, Xiaodong; Fulp, Alan Bradley

Agent Spruson & Ferguson

Pub. Number AU-A-2004253447

PCT Pub. Number WO2005/002503

Priority 10/845,287 12.05.04 US; 60/470,393 13.05.03 US

Filing date 13 May 2004

Wipo publication date 13 January 2005

International Classifications

C07D 403/10 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

24 November 2005 PCT application entered the National Phase

  PCT publication WO2005/002503 Priority application(s): WO2005/002503

9 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004253455-Modulation of survivin expression

2004253444-Beta-glucan-containing products, methods of making same, and uses therefor